Clinical Trial Update: The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 studies assessing intranasal insulin's effect on hepatic and intestinal triglyceride-ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hyperlipidemia | Phase 2, Phase 3 | Status: COMPLETED